Tech Company Financing Transactions
Arsanis Funding Round
Arsanis, operating out of Waltham, scored $10 million in investment from OrbiMed, Polaris Partners and SV Health Investors.
Transaction Overview
Company Name
Announced On
2/8/2011
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds from the initial financing will be used to advance several programs in the anti-microbial infectious disease area.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
890 Winter St. 230
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Not Recorded
Overview
Arsanis (NASDAQ: ASNS) is a biosciences company developing infectious disease treatments based on bacterial protein and carbohydrate antigens.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
René Russo
Chief Medical Officer
Chris Stevens
Chief Operating Officer
Michael Gray
Chief Scientific Officer
Eszter Magy
VP - Bus. Development
David Mantus
Browse more venture capital transactions:
Prev: 2/8/2011: Elenza venture capital transaction
Next: 2/8/2011: Tower Cloud venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs